-
Je něco špatně v tomto záznamu ?
Radiosensitizing potential of Plumbagin in B16F1 melanoma tumor cells through mitochondrial mediated programmed cell death
Bola Sadashiva Satish Rao, Mandala Rayabandla Sunil Kumar, Shubhankar Das, Kiran Aithal, Nayanabhirama Udupa
Jazyk angličtina Země Česko
Typ dokumentu hodnotící studie, práce podpořená grantem
- Klíčová slova
- plumbagin,
- MeSH
- adjuvancia imunologická MeSH
- apoptóza * MeSH
- chemoradioterapie * MeSH
- chemorezistence MeSH
- cytochromy c MeSH
- fytogenní protinádorové látky MeSH
- intracelulární membrány MeSH
- kaspasa 3 MeSH
- melanom * terapie MeSH
- mitochondriální membrány * MeSH
- myši MeSH
- nádorový supresorový protein p53 MeSH
- naftochinony * terapeutické užití MeSH
- oxidační stres MeSH
- PARP inhibitory MeSH
- Plumbaginaceae MeSH
- poškození DNA MeSH
- protein X asociovaný s bcl-2 MeSH
- radiosenzibilizující látky MeSH
- superoxidy terapeutické užití MeSH
- techniky in vitro MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- hodnotící studie MeSH
- práce podpořená grantem MeSH
The radiosensitizing potential of Plumbagin (PLB) against chemo- and radioresistant B16F1 melanoma cells growing in vitro was investigated. Clonogenic assay revealed a sensitization enhancement ratio (SER) of 1.5 for PLB treatment in combination with radiation. PLB pretreatment for 1 h prior to radiation resulted in elevated intracellular ROS levels compared to the group treated with radiation alone. Alkaline comet assay analysis revealed PLB's potential to enhance the radiation induced DNA damage. Cell cycle studies have shown enhanced G2/M arrest for combination treatment of PLB with radiation. Cell death exerted by PLB combination was mainly through programmed cell death, involving the depletion of mitochondrial membrane potential, increase in the expression of p53, Bax, Cytochrome c, PARP and Caspase 3 cleavage. In conclusion, this study demonstrates the radiosensitizing potential of PLB to inhibit the growth of melanoma cells in vitro, which may be attributed to the oxidative stress and DNA damage leading to enhanced mitochondria-mediated programmed cell death. Also, this study demonstrate the ability of PLB to augment ionizing radiation induced tumor cell kill which further warrant the avenue for the development of a clinically useful radiosensitizer.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15040350
- 003
- CZ-PrNML
- 005
- 20160622101654.0
- 007
- ta
- 008
- 160105s2015 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2015.07.003 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Rao, Bola Sadashiva Satish $u Department of Radiation Biology & Toxicology, School of Life Sciences, Manipal University, Karnataka 576 104, India
- 245 10
- $a Radiosensitizing potential of Plumbagin in B16F1 melanoma tumor cells through mitochondrial mediated programmed cell death / $c Bola Sadashiva Satish Rao, Mandala Rayabandla Sunil Kumar, Shubhankar Das, Kiran Aithal, Nayanabhirama Udupa
- 504 __
- $a Literatura
- 520 9_
- $a The radiosensitizing potential of Plumbagin (PLB) against chemo- and radioresistant B16F1 melanoma cells growing in vitro was investigated. Clonogenic assay revealed a sensitization enhancement ratio (SER) of 1.5 for PLB treatment in combination with radiation. PLB pretreatment for 1 h prior to radiation resulted in elevated intracellular ROS levels compared to the group treated with radiation alone. Alkaline comet assay analysis revealed PLB's potential to enhance the radiation induced DNA damage. Cell cycle studies have shown enhanced G2/M arrest for combination treatment of PLB with radiation. Cell death exerted by PLB combination was mainly through programmed cell death, involving the depletion of mitochondrial membrane potential, increase in the expression of p53, Bax, Cytochrome c, PARP and Caspase 3 cleavage. In conclusion, this study demonstrates the radiosensitizing potential of PLB to inhibit the growth of melanoma cells in vitro, which may be attributed to the oxidative stress and DNA damage leading to enhanced mitochondria-mediated programmed cell death. Also, this study demonstrate the ability of PLB to augment ionizing radiation induced tumor cell kill which further warrant the avenue for the development of a clinically useful radiosensitizer.
- 650 12
- $a melanom $x terapie $7 D008545
- 650 12
- $a chemoradioterapie $7 D059248
- 650 _2
- $a chemorezistence $7 D019008
- 650 _2
- $a fytogenní protinádorové látky $7 D000972
- 650 _2
- $a adjuvancia imunologická $7 D000276
- 650 12
- $a naftochinony $x terapeutické užití $7 D009285
- 650 _2
- $a superoxidy $x terapeutické užití $7 D013481
- 650 _2
- $a Plumbaginaceae $7 D029606
- 650 _2
- $a intracelulární membrány $7 D007425
- 650 12
- $a mitochondriální membrány $7 D051336
- 650 12
- $a apoptóza $7 D017209
- 650 _2
- $a radiosenzibilizující látky $7 D011838
- 650 _2
- $a nádorový supresorový protein p53 $7 D016159
- 650 _2
- $a protein X asociovaný s bcl-2 $7 D051028
- 650 _2
- $a cytochromy c $7 D045304
- 650 _2
- $a PARP inhibitory $7 D000067856
- 650 _2
- $a kaspasa 3 $7 D053148
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a poškození DNA $7 D004249
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a zvířata $7 D000818
- 653 00
- $a plumbagin
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kumar, Mandala Rayabandla Sunil $u Department of Radiation Biology & Toxicology, School of Life Sciences, Manipal University, Karnataka 576 104, India
- 700 1_
- $a Das, Shubhankar $u Department of Radiation Biology & Toxicology, School of Life Sciences, Manipal University, Karnataka 576 104, India
- 700 1_
- $a Aithal, Kiran $u Department of Radiation Biology & Toxicology, School of Life Sciences, Manipal University, Karnataka 576 104, India $7 gn_A_00002718
- 700 1_
- $a Udupa, Nayanabhirama $u Research Directorate, Manipal University, Karnataka 576 104, India
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 13, č. 4 (2015), s. 279-288 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2015/04/04.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20150522215938 $b ABA008
- 991 __
- $a 20160622101835 $b ABA008
- 999 __
- $a ok $b bmc $g 1101598 $s 923577
- BAS __
- $a 3
- BMC __
- $a 2015 $b 13 $c 4 $d 279-288 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK137 $d 20160622 $a NLK 2016-01/dk